A kelch family protein Nd1-L functions as a metastasis suppressor in cancer cells via Rho family proteins mediated mechanism

International Journal of Oncology

Volumn 36, Issue 2, 2010, Pages 427-434

  Ohta, Yoshihito ^a   Fujimura, Lisa ^a   Nishio, Saori ^a   Arima, Masafumi ^a   Sakamoto, Akemi ^a   Shimada, Hideaki ^a   Ochiai, Takenori ^a   Tokuhisa, Takeshi ^a   Hatano, Masahiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Actin cytoskeleton; Cancer metastasis; Kelch protein

Indexed keywords

ACTIN; CELL PROTEIN; PROTEIN CDC42; PROTEIN ND1 L; RAC PROTEIN; RHO FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; LIVER METASTASIS; LUNG METASTASIS; MELANOMA; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

ACTINS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOSKELETON; MICE; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; NIH 3T3 CELLS; PROTEINS; RHO GTP-BINDING PROTEINS; RNA INTERFERENCE; TRANSFECTION;

EID: 75449116719     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000516     Document Type: Article

References (30)

1. Adams J, Kelso R and Cooley L: The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 10: 17-24, 2000.
2. Bardwell VJ and Treisman R: The POZ domain: a conserved protein-protein interaction motif. Genes Dev 8: 1664-1677, 1994.
3. Prag S and Adams JC: Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. BMC Bioinformatics 4: 42, 2003.
4. Xue F and Cooley L: Kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 72: 681-693, 1993.
5. Robinson DN and Cooley L: Drosophila kelch is an oligomeric ring canal actin organizer. J Cell Biol 138: 799-810, 1997.
6. Philips J and Herskowitz I: Identification of Kel1p, a kelch domain-containing protein involved in cell fusion and morphology in Saccharomyces cerevisiae. J Cell Biol 143: 375-389, 1998.
7. Furukawa M and Xiong Y: BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 25: 162-171, 2005.
8. Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW and Hannink M: Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem 280: 30091-30099, 2005.
9. Schaefer H and Rongo C: KEL-8 is a substrate receptor for CUL3-dependent ubiquitin ligase that regulates synaptic glutamate receptor turnover. Mol Biol Cell 17: 1250-1260, 2006.
10. Sasagawa K, Matsudo Y, Kang M, et al: Identification of Nd1, a novel murine kelch family protein, involved in stabilization of actin filaments. J Biol Chem 277: 44140-44146, 2002.
11. Matsudo Y, Takamori Y, Fujimura L, et al: Overexpression of Nd1, a novel Kelch family protein, in the heart of transgenic mice protects against doxorubicin-induced cardiomyopathy. Transgenic Res 15: 573-781, 2006.
12. Fujimura L, Matsudo Y, Kang M, Takamori Y, Tokuhisa T and Hatano M: Protective role of Nd1 in doxorubicin-induced cardiotoxicity. Cardiovasc Res 64: 315-321, 2004.
13. Padmanabhan B, Tong IK, Ohta T, et al: Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 21: 689-700, 2006.
14. Kim TA, Lim J, Ota S, et al: NRP/B, a novel nuclear matrix protein, associates with p110 (RB) and is involved in neuronal differentiation. J Cell Biol 141: 553-566, 1998.
15. Liang XQ, Avraham HK, Jiang S and Avraham S: Genetic alterations of the NRP/B gene are associated with human brain tumors. Oncogene 23: 5890-5900, 2004.
16. Bu X, Avraham KH, Li X, et al: Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells. Oncogene 24: 2398-2409, 2005.
17. Dimitroff CJ, Sharma A and Bernacki RJ: Cancer metastasis: a search for therapeutic inhibition. Cancer Invest 16: 279-290, 1998.
18. Lauffenburger DA and Horwitz AF: Cell migration: a physically integrated molecular process. Cell 84: 359-369, 1996.
19. Yamazaki D, Kurisu S and Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci 97: 379-386, 2005.
20. van't Veer LJ, Dai H, van de Zijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002.
21. Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003.
22. Minn AJ, Gupta GP, Siegel PM, et al: Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524, 2005.
23. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC and Schabel FM Jr: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-2439, 1975.
24. Wai PY, Mi Z, Guo H, et al: Osteopontin silencing by small interfering RNA suppress in vitro and in vivo CT26 murine colon adenocarcinama metastasis. Carcinogenesis 26: 741-751, 2005.
25. Ren XD, Kiosses WB and Schwartz MA: Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18: 578-585, 1999.
26. Zondag GC, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA and Collard JG: Oncogenic Ras down-regulates Rac activity, which leads to increased Rho activity and epithelial mesenchymal transition. J Cell Biol 149: 775-782, 2000.
27. Fidler IJ and Radinsky R: Genetic control of cancer metastasis. J Natl Cancer Inst 82: 166-168, 1990.
28. Saiki I: Cell adhesion molecules and cancer metastasis. Jpn J Pharmacol 75: 215-242, 1997.
29. Schmita AAP, Govek EE, Bottner B and van Aelst L: Rho GTPases: signaling, migration and invasion. Exp Cell Res 261: 1-12, 2000.
30. Fiordalisi JJ, Keller PJ and Cox AD: PRL tyrosine phosphatases regulate Rho family GTPases to promote invasion and motility. Cancer Res 66: 3153-3161, 2006.